Dashboard
1
High Debt company with Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate -27.03% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Flat results in Dec 24
3
With ROE of 2.33%, it has a Expensive valuation with a 0.49 Price to Book Value
4
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.46%
0%
0.46%
6 Months
-5.98%
0%
-5.98%
1 Year
-7.17%
0%
-7.17%
2 Years
-44.44%
0%
-44.44%
3 Years
-43.59%
0%
-43.59%
4 Years
-40.38%
0%
-40.38%
5 Years
-38.38%
0%
-38.38%
China Traditional Chinese Medicine Holdings Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
1.58%
EBIT Growth (5y)
-27.03%
EBIT to Interest (avg)
7.07
Debt to EBITDA (avg)
0.23
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.66
Tax Ratio
86.88%
Dividend Payout Ratio
30.17%
Pledged Shares
0
Institutional Holding
0.37%
ROCE (avg)
7.63%
ROE (avg)
6.83%
Valuation key factors
Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
0.49
EV to EBIT
12.77
EV to EBITDA
4.80
EV to Capital Employed
0.45
EV to Sales
0.52
PEG Ratio
NA
Dividend Yield
0.09%
ROCE (Latest)
3.51%
ROE (Latest)
2.33%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
20,024.60
16,634.10
20.38%
Operating Profit (PBDIT) excl Other Income
2,504.80
2,472.90
1.29%
Interest
219.90
256.60
-14.30%
Exceptional Items
-23.60
-212.20
88.88%
Consolidate Net Profit
1,542.70
838.10
84.07%
Operating Profit Margin (Excl OI)
64.20%
73.00%
-0.88%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 20.38% vs -27.56% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 84.07% vs -67.25% in Dec 2022
About China Traditional Chinese Medicine Holdings Co. Ltd. 
China Traditional Chinese Medicine Holdings Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






